Parallel 6 Named One of the 2016 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook Magazine

Share Article

Clinical Reach is an mClinical™ platform for patient enrollment, engagement, and management of clinical trials worldwide.

Parallel 6

Parallel 6

We are excited to see this momentum behind Clinical Reach, and that some of the largest pharma companies see that the Clinical Reach platform gives clinical trial stakeholders immediate access to the data they need to make informed decisions, faster.

Parallel 6, the leading software as a service (SaaS) provider of mobile enrollment and engagement solutions for clinical research and public sector organizations, announced today that they were named one of the 2016 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook magazine, which covers the latest developments in the pharmaceutical industry.

“During the evaluation process, it was evident that Parallel 6 clearly deserves to be recognized as a leader in eClinical technology solutions for the pharmaceutical industry and we are proud to honor Parallel 6 and their flagship product, Clinical Reach this year”, said Stacey Smith, Managing Editor of Pharma Tech Outlook.

The Clinical Reach platform operates in a secure HIPAA compliant cloud, is 21 CFR Part 11 / Annex 11 compliant and has been independently audited. Clinical Reach is an end-to-end solution that empowers potential participants to digitally qualify, consent, enroll, and engage in a clinical trial using any internet enabled device.

“We are excited to see this momentum behind Clinical Reach, and that some of the largest pharma companies see that the Clinical Reach platform gives clinical trial stakeholders immediate access to the data they need to make informed decisions, faster.” said Allan Camaisa, CEO and Chairman of Parallel 6.

“Our patented platform powers virtual, hybrid, and site-based trials in multi-language, multi-country configurations anywhere in the world. Team members can view trial information, push notifications and input clinical data in real time from the palm of their hands. All of this gives the clinical operations team the visibility and insights into potential issues before they manifest, enabling them to de-risk the trial in real time throughout the life of the trial from a single interface.”says President and CTO | Founder of Parallel 6, David Turner.

For more information on how Clinical Reach is leveraging mobile technologies to streamline clinical trials, join Sanjeev Bhavnani, M.D. Cardiologist, Wireless Health and Digital Medicine Scripps Health, and Brad Pruitt, M.D., MBA, Chief Medical Officer of Parallel 6 for what will be an informative and engaging webinar: Taking On The Triple Aim of Clinical Trials - How Mobile Clinical Platforms Are Improving Data Quality, Reducing Trial Costs & Empowering the Patient Experience. Wednesday, April 20th, 2016. Click here to register for the webinar.

About Parallel6
Parallel 6, is an innovative software as a service provider of mobile enrollment, and engagement solutions for clinical research, health, and public sector organizations. Clinical Reach™ is an mClinical™ platform for patient enrollment, engagement, and management of clinical trials worldwide. Additional solutions include GovReach™ for government agencies. GovReach accelerates government-to-citizen and internal government-digital efficiency, transparency, and engagement. The firm’s headquarters is in San Diego, CA with additional offices in Washington D.C. For more information, visit http://www.parallel6.com/.

About Pharma Tech Outlook
Published from Fremont, California, Pharma Tech Outlook is a print magazine that covers most important and latest developments in pharmaceutical industries. A distinguished panel comprising of top IT decision makers, CIOs and CTOs from the pharma and life sciences industry, as well as the Pharma Tech Outlook editorial board finalized the “Top 10 eClinical Trial Management Solution Providers 2016” in the U.S. and shortlisted the best vendors and consultants. For more info: http://www.pharmatechoutlook.com/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aimee Eucce
@Parallel6
Follow >
Visit website